Veru
VERU
#10527
Rank
NZ$65.26 M
Marketcap
NZ$3.83
Share price
-0.23%
Change (1 day)
-15.98%
Change (1 year)

Earnings for Veru (VERU)

Earnings in 2026 (TTM): -NZ$48.37 Million

According to Veru's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$53.31 Million, an increase over its 2024 earnings that were of -NZ$68.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veru from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$48.37 Million-9.26%
2025 -NZ$53.31 Million-21.84%
2024 -NZ$68.2 Million-49.67%
2023 -NZ$0.14 Billion-31.87%
2022 -NZ$0.2 Billion673.72%
2021 -NZ$25.71 Million-375.47%
2020 NZ$9.33 M-157.74%
2019 -NZ$16.16 Million-32.09%
2018 -NZ$23.8 Million1.17%
2017 -NZ$23.53 Million-1349.01%
2016 NZ$1.88 M-85.97%
2015 NZ$13.42 M99.18%
2014 NZ$6.73 M-51.18%
2013 NZ$13.8 M-33.9%
2012 NZ$20.88 M108.3%
2011 NZ$10.02 M3.75%
2010 NZ$9.66 M-20.61%
2009 NZ$12.17 M136.88%
2008 NZ$5.13 M
2006 -NZ$0.15 Million26.36%
2005 -NZ$0.12 Million
2000 -NZ$3.89 Million
1998 -NZ$5.25 Million-37.72%
1997 -NZ$8.42 Million-47.64%
1996 -NZ$16.08 Million37.12%
1995 -NZ$11.73 Million-15.38%
1994 -NZ$13.86 Million875%
1993 -NZ$1.43 Million-50%
1992 -NZ$2.85 Million-0%
1991 -NZ$2.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.15 Billion 186.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.25 Million-34.73%๐Ÿ‡บ๐Ÿ‡ธ USA